 |
 |
Cancer Research Studies
Early Detection: Ovarian Cancer
Early Detection: Ovarian Cancer
Study Title:
Serum
Proteomics: For Detection of Ovarian Cancer Using the Correlogic Systems,
Inc. Serum Pattern Blood Test System
What is the purpose of this study?
In the United States, more than 20,000 women a
year are diagnosed with ovarian cancer. Most of the women are diagnosed
in the later stages of the disease.
The Correlogic Ovarian Test (OvaCheck) is a blood test being investigated for its use in the early detection of ovarian cancer.
Am I a candidate for this study?
To participate in this ovarian cancer research study you will need
to:
- Are you 18 years or older?
- Are you scheduled for gynecologic surgery?
- Are you willing to provide a blood sample?
What do I need to do?
To participate in the ovarian cancer research study you will need to:
- Give researchers permission to collect information about your health history
- Complete a brief questionnaire
- Give two blood samples that amount to less than 4 tablespoons of blood
Why should I participate?
You can make a difference by helping researchers
determine if a blood test like this one can help detect ovarian cancer
early. Detecting ovarian cancer early can save lives.
If you are interested in participating in this ovarian cancer
research study, please contact:
Felicia Nash-DeBraux, research associate
Holy Cross Hospital, Clinical Research Department
301.754.7985
nashf@holycrosshealth.org
Principle Investigator: James Barter, MD, gynecology oncology surgeon
About Our Program
Prevention & Early Detection
Studies
Treatment Studies
Survivor Studies
Related Information